Filana Therapeutics, Inc. (FLNA : NASDAQ)
Common Stock
$1.03
USD
+0.29 (39.28%)
Last updated: 2026-09-22
Get FLNA alerts:
FLNA
Filana Therapeutics, Inc.
WealthAwesomePerformance
1 Day
+39.28%
1 Week
+47.14%
1 Month
+7.29%
YTD
-14.88%
Key Statistics
Market Cap
$35.72M
52W High
$4.98
52W Low
$0.67
P/E Ratio
-
50 Day MA
$0.91
200 Day MA
$1.61
Beta
-0.70
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/22/2026 | $0.98 | $1.30 | $0.90 | $1.03 | $1.03 | 93,522,837 |
| 9/21/2026 | $0.73 | $0.77 | $0.73 | $0.74 | $0.74 | 336,345 |
| 9/18/2026 | $0.72 | $0.73 | $0.71 | $0.73 | $0.73 | 122,800 |
| 9/17/2026 | $0.69 | $0.72 | $0.68 | $0.72 | $0.72 | 273,234 |
| 9/16/2026 | $0.69 | $0.70 | $0.67 | $0.68 | $0.68 | 379,600 |
| 9/15/2026 | $0.73 | $0.73 | $0.68 | $0.70 | $0.70 | 446,000 |
| 9/14/2026 | $0.77 | $0.77 | $0.71 | $0.72 | $0.72 | 379,300 |
| 9/11/2026 | $0.81 | $0.81 | $0.77 | $0.77 | $0.77 | 309,600 |
| 9/10/2026 | $0.80 | $0.81 | $0.77 | $0.81 | $0.81 | 303,300 |
| 9/9/2026 | $0.79 | $0.81 | $0.76 | $0.81 | $0.81 | 271,300 |
Analyst Price Targets
Based on analyst covering FLNA · as of Sep 17, 2026
Wall Street analysts forecast FLNA stock price to rise 531.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
US$6.50
+531.1% Upside
Current Price
US$1.03
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on FLNA's historical volatility
30-Day Vol
113.8%
Annualized
90-Day Vol
87.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$0.86
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.97 | US$0.66 – US$1.44 |
| 60 trading days | US$0.91 | US$0.52 – US$1.59 |
| 90 trading days | US$0.86 | US$0.44 – US$1.70 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Filana Therapeutics, Inc.
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-12.69M
- Profit Margin
- 0.00%
- ROE (TTM)
- -55.79%
- EPS (Diluted)
- -0.87
- Book Value
- 1.32
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About FLNA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| LHSW | Lianhe Sowell International Group Ltd Ordinary Shares | $0.89 | +105.33% |
| KFIIR | K&F Growth Acquisition Corp. II Rights | $0.09 | +73.36% |
| ZEO | Zeo Energy Corp. | $0.49 | +57.04% |
| RAIN | Rain Enhancement Technologies Holdco, Inc. Class A Common Stock | $1.02 | +54.31% |
| NBRGR | Newbridge Acquisition Limited Rights | $0.36 | +53.19% |
| GRML | Greenland Mines Ltd | $14.15 | +50.21% |
| CWD | CaliberCos Inc. Class A Common Stock | $0.73 | +40.33% |
| VKTX | Viking Therapeutics Inc | $40.85 | +35.67% |